In vitro and in vivo antileprosy activities of benzoxazinorifamycin and clarithromycin
Saito, H.; Tomioka, H.; Sato, K.
International Journal of Leprosy and Other Mycobacterial Diseases 60(4): 723-724
1992
ISSN/ISBN: 0148-916X Accession: 031855633
Full Text Article emailed within 1 workday: $29.90
Related References
Hajime Saito,H. Saito,K. Sato,T. Hidaka 1993: Antileprosy Action of Ofloxacin in Combination with Rifampicin or DDS, and Benzoxazinorifamycin in Mice, and theirIn Vitro Activities against Leprosy Bacilli Drugs 45(3 Suppl): 221-222Tomioka, H.; Saito, H. 1993: In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648 International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 61(2): 255-258
Akaki, T.; Sato, K.; Shimizu, T.; Tomioka, H.; Kawahara, S. 1997: In vivo activities of benzoxazinorifamycin KRM-1648, clarithromycin, and levofloxacin, or combination of KRM-1648 with diclofenac sodium against Mycobacterium avium infection induced in mice Kekkaku: 72(8): 491-497
Saito, H.; Tomioka, H.; Sato, K.; Hirata, T.; Hidaka, T. 1994: In vitro and in vivo activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Abstracts of the General Meeting of the American Society for Microbiology 94: 192
Hirata, T.; Saito, H.; Tomioka, H.; Sato, K.; Jidoi, J.; Hosoe, K.; Hidaka, T. 1995: In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 39(10): 2295-2303
Yamamoto, Y.; Saito, H.; Tomioka, H.; Sato, K.; Yamane, T.; Yamashita, K.; Hosoe, K.; Hidaka, T. 1992: In vitro and in vivo activities of KRM-1648, a newly synthesized benzoxazinorifamycin, against Mycobacterium marinum Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 277(2): 204-209
Hardy, D.J.; Swanson, R.N.; Rode, R.A.; Marsh, K.; Shipkowitz, N.L.; Clement, J.J. 1990: Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans Antimicrobial Agents and ChemoTherapy 34(7): 1407-1413
Sato, K.; Akaki, T.; Tomioka, H. 1998: Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages Journal of Antimicrobial ChemoTherapy 41(1): 77-83
Ono, T.; Numata, K.; Nagate, T.; Mitsuhashi, S.; Inoue, M. 1996: In vitro and in vivo antibacterial activities of clarithromycin Chemotherapy 42(3): 159-169
Fernandes, P.B.; Hardy, D.J.; McDaniel, D.; Hanson, C.W.; Swanson, R.N. 1989: In vitro and in vivo activities of clarithromycin against Mycobacterium avium Antimicrobial Agents and ChemoTherapy 33(9): 1531-1534
Hajime Saito; Haruaki Tomioka; Katsumasa Sato; Satoshi Dekio 1994: In vitro and in vivo activities of clarithromycin against the Mycobacterium avium complex International Journal of Antimicrobial Agents 4(3): 175-181
Fattorini, L.; Li, B.; Piersimoni, C.; Tortoli, E.; Xiao, Y.; Santoro, C.; Ricci, M.L.; Orefici, G. 1995: In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium Antimicrobial Agents and ChemoTherapy 39(3): 680-685
Morimoto, S.; Nagate, T.; Sugita, K.; Ono, T.; Numata, K.; Miyachi, J.; Misawa, Y.; Yamada, K.; Omura, S. 1990: Chemical modification of erythromycins. III. in vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032 Journal of Antibiotics 43(3): 295-305
Morimoto, S.; Nagate, T.; Sugita, S.; Ono, T.; Numata, K.; Miyachi, J.; Misawa, Y.; Yamada, K.; Omura, S. 1990: Chemical modification of erythromycins. III, In vitro and In vivo antibacterial activities of new semisynthetic 6-O-methylerythromycins A, TE-031 (clarithromycin) and TE-032 Journal of Antibiotics (Tokyo 1968) 43(3): 295-305
Sato, K.; Tomioka, H.; Saito, H.; Kawahara, S.; Hidaka, T. 1996: In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Kekkaku: 71(8): 459-464